Results 31 to 40 of about 1,361,126 (321)

High prevalence of anelloviruses in vitreous fluid of children with seasonal hyperacute panuveitis. [PDF]

open access: yes, 2012
Seasonal hyperacute panuveitis (SHAPU) is a potentially blinding ocular disease occurring in Nepal that principally affects young children. Random amplification of partially purified vitreous fluid (VF)-derived nucleic acid revealed the presence of human
Baarsma, G Seerp   +8 more
core   +1 more source

Marked Choroidal Thinning Observed after Intravitreal Brolucizumab Injection

open access: yesCase Reports in Ophthalmology, 2023
Introduction: Here, we report a case of severe intraocular inflammation (IOI) and prominent choroidal thinning following the initial intravitreal brolucizumab injection (IVBr). Case Presentation: The patient was a 75-year-old Japanese man with type 2 age-
Yoshiki Ueta   +3 more
doaj   +1 more source

Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: A case series

open access: yesTaiwan Journal of Ophthalmology, 2022
As a continuing demand for booster shots against SARS-CoV-2, ocular adverse events following the coronavirus disease-2019 (COVID-19) vaccines can cause significant visual impairment, and they warrant a high awareness and detailed documentation of ...
Ling-Uei Wang   +6 more
doaj   +1 more source

A double masked randomised 4-week, placebo-controlled study in the USA, Thailand and Taiwan to compare the efficacy of oral valganciclovir and topical 2% ganciclovir in the treatment of cytomegalovirus anterior uveitis: study protocol. [PDF]

open access: yes, 2019
IntroductionCytomegalovirus (CMV) anterior uveitis is a recognised cause of anterior uveitis in immunocompetent patients and is preventable cause of vision loss.
Acharya, Nisha R   +13 more
core   +2 more sources

Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and/or Vascular Occlusion after Brolucizumab Treatment.

open access: yesOphthalmology Retina, 2020
PURPOSE Recent reports have described a spectrum of uncommon findings of intraocular inflammation (IOI), retinal vasculitis and/or retinal vascular occlusion in patients with neovascular age-related macular degeneration (nAMD) treated with intravitreal ...
C. Baumal   +7 more
semanticscholar   +1 more source

A comparative study of various topical nonsteroidal anti-inflammatory drugs to steroid drops for control of post cataract surgery inflammation

open access: yesOman Journal of Ophthalmology, 2016
Background: Postoperative inflammation continues to be a cause of patient discomfort, delayed recovery, and in some cases, suboptimal visual results. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) and steroid are commonly used in the management ...
Anu Malik   +3 more
doaj   +1 more source

Adverse events associated with intraocular injection of anti-VEGF(bevacizumab) in retinal vein ccclusion: a case report [PDF]

open access: yes, 2015
Introduction: Antiangiogenic agents are often administered for treatment of Branch Retinal Vein Occlusion (BRVO). Among them, Bevacizumab has noticeable antiangiogenic and antiedemigenic properties and possesses great capacity to penetrate the retinal ...
ARTICO, Marco   +7 more
core   +1 more source

Heavy Silicone Oil and Intraocular Inflammation [PDF]

open access: yesBioMed Research International, 2014
In the past two decades, many advances have been made in vitrectomy instrumentation, surgical techniques, and the use of different tamponade agents. These agents serve close retinal breaks, confine eventual retinal redetachment, and prevent proliferative vitreoretinopathy (PVR). Long-acting gases and silicone oil are effective internal tamponade agents;
Francesco Morescalchi   +7 more
openaire   +5 more sources

Rhegmatogenous retinal detachment masquerading as exudative panuveitis with intense anterior chamber inflammatory reaction. [PDF]

open access: yes, 2020
Purpose:This is a retrospective case report illustrating the diagnostic and therapeutic challenges associated with a chronic rhegmatogenous retinal detachment masquerading as a severe panuveitis with intense anterior chamber inflammation.
Bhisitkul, Robert B   +3 more
core  

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

open access: yes, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy